Natalia Baran

Also affiliated with The University of Texas MD Anderson Cancer Center, University of South Dakota, University Hospital of Bern, Azienda USL di Bologna, National Research Center for Hematology Russian Academy of Medical Sciences

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 33 papers. Top paper: “Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials”.

Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials

Nature Medicine(2023)10.1038/s41591-022-02103-8

N/A

4.3DataRank · unranked

388 citations

Naval Daver, Mikhila Mahendra, Jixiang Zhang, Carlos Kamiya-Matsuoka, Funda Meric‐Bernstam +44 more

Glutaminase inhibition in combination with azacytidine in myelodysplastic syndromes: a phase 1b/2 clinical trial and correlative analyses

Nature Cancer(2024)10.1038/s43018-024-00811-3

N/A

0.878DataRank · unranked

37 citations

Divij Verma, Natalia Baran, Tushar D. Bhagat, Anna Skwarska, Alessia Lodi +42 more

Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells

Blood(2021)10.1182/blood.2020007748

N/A

0.848DataRank · unranked

284 citations

Rafet Basar, Elif Gokdemir, Natalia Baran, Nadima Uprety, Ana Karen Nunez Cortes +56 more

Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia

Signal Transduction and Targeted Therapy(2022)10.1038/s41392-021-00870-3

N/A

0.787DataRank · unranked

189 citations

Bridget Riley‐Gillis, Lina Han, Yannan Jia, Alessia Lodi, Haijiao Zhang +36 more

Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood–Derived NK Cells Facilitates CAR-like Responses Against CD30+ Malignancies

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0164

N/A

0.757DataRank · unranked

154 citations

Nancy D. Marín, Mecit Kaplan, Pinaki P. Banerjee, Melissa M. Berrien-Elliott, Michelle Becker‐Hapak +38 more

Comprehensive characterization of IFNγ signaling in acute myeloid leukemia reveals prognostic and therapeutic strategies

Nature Communications(2024)10.1038/s41467-024-45916-6

N/A

0.631DataRank · unranked

66 citations

Patrick K. Reville, Mhd Yousuf Yassouf, Fatima Zahra Jelloul, Christopher Ly, Poonam N. Desai +27 more

Inhibition of mitochondrial complex I reverses NOTCH1-driven metabolic reprogramming in T-cell acute lymphoblastic leukemia

Nature Communications(2022)10.1038/s41467-022-30396-3

N/A

0.624DataRank · unranked

63 citations

Alessia Lodi, Yogesh Dhungana, Shelley M. Herbrich, Meghan Collins, Shannon Sweeney +50 more

Activated B cells suppress T-cell function through metabolic competition

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2022-005644

N/A

0.542DataRank · unranked

36 citations

Rafet Başar, Yuefan Huang, Fang Wang, Natalia Baran, Pinaki P. Banerjee +22 more

Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and/or purine biosynthesis in vitro

Biochemical Pharmacology(2023)10.1016/j.bcp.2023.115981

N/A

0.442DataRank · unranked

18 citations

Yongwei Su, Shraddha Patel, Cassandra L. Ramage, Jianlei Zhao, Brianna R. Temby +24 more

Targeting Unc51-like Autophagy Activating Kinase 1 (ULK1) Overcomes Adaptive Drug Resistance in Acute Myelogenous Leukemia

Molecular Cancer Research(2023)10.1158/1541-7786.mcr-22-0343

N/A

0.425DataRank · unranked

16 citations

Sujan Piya, Huaxian Ma, Priyanka Sharma, Qi Zhang, Natalia Baran +10 more

Transcriptional and phenotypic heterogeneity underpinning venetoclax resistance in AML

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.01.27.577579

N/A

0.360DataRank · unranked

10 citations

Natalia Baran, Yuefan Huang, Cassandra L. Ramage, Laurie Cooper, Shan He +7 more

Impact of p53-associated acute myeloid leukemia hallmarks on metabolism and the immune environment

Frontiers in Pharmacology(2024)10.3389/fphar.2024.1409210

N/A

0.345DataRank · unranked

9 citations

Luca Gazzola, Shubhankar Dash, Patryk Firmanty, Binsah George, Vakul Mohanty +3 more

Multifaced Anticancer Potential of Doxorubicin: Spotlight on Breast Cancer

Diseases & Research(2025)10.54457/dr.202402015

N/A

0.345DataRank · unranked

9 citations

Biswajit Das, Natalia Baran, Swain Laxita

Targeting MDSCs in cancer: emerging immunotherapeutic and metabolic strategies

Frontiers in Immunology(2026)10.3389/fimmu.2026.1749965

N/A

0.330DataRank · unranked

8 citations

Patryk Firmanty, Monika Chomczyk, Vakul Mohanty, Wenxue Ma, Natalia Baran +1 more

Glutaminase inhibition in combination with azacytidine in myelodysplastic syndromes: Clinical efficacy and correlative analyses

Research Square(2023)10.21203/rs.3.rs-2518774/v1

N/A

0.312DataRank · unranked

7 citations

Courtney D. DiNardo, Tushar D. Bhagat, Natalia Baran, Alessia Lodi, Kapil Saxena +38 more

Targeting Oxidative Phosphorylation with a Mitochondrial Complex I Inhibitor is limited by Mechanism-based Toxicity

Research Square(2022)10.21203/rs.3.rs-1506700/v1

N/A

0.269DataRank · unranked

5 citations

Timothy A. Yap, Naval Daver, Mikhila Mahendra, Jixiang Zhang, Carlos Kamiya-Matsuoka +43 more

CIS checkpoint deletion enhances the fitness of cord blood derived natural killer cells transduced with a chimeric antigen receptor

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.03.29.014472

N/A

0.224DataRank · unranked

2 citations

Rafet Basar, Elif Gokdemir, Natalia Baran, Nadima Uprety, Ana Karen Nunez Cortes +55 more

Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and purine biosynthesis

Research Square(2023)10.21203/rs.3.rs-2843025/v1

N/A

0.165DataRank · unranked

2 citations

Katie Hege-Hurrish, Yongwei Su, Shraddha Patel, Cassandra L. Ramage, Jenna L. Carter +22 more

Targeting DNA2 Overcomes Metabolic Reprogramming in Multiple Myeloma

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.02.22.529457

N/A

0.104DataRank · unranked

1 citations

Feiyang Ma, Pamela Lockyer, Natalia Baran, Jintan Liu, C. Ellen Jackson +27 more

Data from Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood–Derived NK Cells Facilitates CAR-like Responses Against CD30+ Malignancies

(2023)10.1158/1078-0432.c.6530711.v1

N/A

0.104DataRank · unranked

1 citations

Nancy D. Marín, Mecit Kaplan, Pinaki P. Banerjee, Melissa M. Berrien-Elliott, Michelle Becker‐Hapak +38 more

Feasibility and Safety of Targeting Mitochondria Function and Metabolism in Acute Myeloid Leukemia

Current Pharmacology Reports(2024)10.1007/s40495-024-00378-8

N/A

0DataRank · unranked

3 citations

Monika Chomczyk, Shubhankar Dash, Marina Konopleva, Natalia Baran, Patryk Firmanty

Age-specific induction of mutant p53 drives clonal hematopoiesis and acute myeloid leukemia in adult mice

Cell Reports Medicine(2024)10.1016/j.xcrm.2024.101558

N/A

0DataRank · unranked

5 citations

Rafael Heinz Montoya, Hiroki Akiyama, Lauren B. Ostermann, Shayuan Khazaei, Muharrem Müftüoğlu +9 more

Utilizing Synergistic Potential of Mitochondria-Targeting Drugs for Leukemia Therapy

Frontiers in Oncology(2020)10.3389/fonc.2020.00435

N/A

0DataRank · unranked

41 citations

Jingqi Pei, Natalia Baran, Marina Konopleva, Natalia V. Kirienko, Svetlana Panina

Inhibition of Oxidative Phosphorylation Reverses Bone Marrow Hypoxia Visualized in Imageable Syngeneic B-ALL Mouse Model

Frontiers in Oncology(2020)10.3389/fonc.2020.00991

N/A

0DataRank · unranked

18 citations

Karine G. Harutyunyan, Natalia Baran, Saradhi Mallampati, Malgorzata Anna Zal, Antonio Cavazos +9 more

Proton Density Fat Fraction Micro-MRI for Non-Invasive Quantification of Bone Marrow Aging and Radiation Effects in Mice

Bioengineering(2025)10.3390/bioengineering12040349

N/A

0DataRank · unranked

3 citations

Malakeh Malekzadeh, Ji Eun Lim, Srideshikan Sargur Madabushi, Marco Andrea Zampini, Angela Camacho +6 more

Romaciclib, a CDK8/CDK19 inhibitor, can overcome venetoclax resistance through a combinatorial strategy

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.64898/2025.12.16.693978

N/A

0DataRank · unranked

1 citations

Marta Obacz, Jerzy Woźnicki, Katarzyna Wiklik, Samarpana Chakraborty, Marta Micek +17 more

Dual MYC and GSPT1 Protein Degrader for MYC-Driven Cancers

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.04.24.650490

N/A

0DataRank · unranked

0 citations

Valeria Impedovo, Edward Ayoub, Natalia Baran, Darah A. Scruggs, Hideaki Mizuno +21 more

DYRK1a mediates BAFF-induced noncanonical NF-κB activation to promote autoimmunity and B-cell leukemogenesis

Blood(2021)10.1182/blood.2021011247

N/A

0DataRank · unranked

58 citations

Xiaoping Xie, Zuliang Jie, Lele Zhu, Jin‐Young Yang, Chun‐Jung Ko +8 more

Mitochondrial regulation of GPX4 inhibition–mediated ferroptosis in acute myeloid leukemia

Leukemia(2023)10.1038/s41375-023-02117-2

N/A

0DataRank · unranked

50 citations

Ran Zhao, Lauren B. Ostermann, Ziyi Li, Matthew Tcheng, Samar J. Yazdani +13 more

Targeting the NOTCH1-MYC-CD44 axis in leukemia-initiating cells in T-ALL

Leukemia(2022)10.1038/s41375-022-01516-1

N/A

0DataRank · unranked

32 citations

Ya‐Ling Yang, Seemana Bhattacharya, Priyanka Sharma, Huaxian Ma, Hong Mu +11 more

Advancing the next generation of cancer treatment with circular RNAs in CAR-T cell therapy

Biomedicine & Pharmacotherapy(2024)10.1016/j.biopha.2024.117753

N/A

0DataRank · unranked

30 citations

Juling Xu, Natalia Baran, Wenxue Ma, Sanxiong Huang

Preclinical investigations of the efficacy of the glutaminase inhibitor CB-839 alone and in combinations in chronic lymphocytic leukemia

Frontiers in Oncology(2023)10.3389/fonc.2023.1161254

N/A

0DataRank · unranked

27 citations

Mary Ayres, Natalia Baran, Janice M. Santiago‐O’Farrill, Gamze Bildik, Zhen Lü +3 more

Antileukemia efficacy of the dual BCL2/BCL-XL inhibitor AZD0466 in acute lymphoblastic leukemia preclinical models

Blood Advances(2024)10.1182/bloodadvances.2024013423

N/A

0DataRank · unranked

9 citations

Yizhen Li, Natalia Baran, Yang Xu, Sanaz Ghotbaldini, Qi Zhang Tatarata +11 more